Detalhe da pesquisa
1.
New C(4)- and C(1)-derivatives of furo[3,4-c]pyridine-3-ones and related compounds: evidence for site-specific inhibition of the constitutive proteasome and its immunoisoform.
Bioorg Med Chem Lett
; 24(6): 1571-80, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24534487
2.
The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation.
Viruses
; 13(11)2021 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835118
3.
Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases.
Biochemistry
; 48(2): 379-87, 2009 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19105629
4.
Bisbenzimidazole derivatives as potent inhibitors of the trypsin-like sites of the immunoproteasome core particle.
Biochimie
; 108: 94-100, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25446655
5.
Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
J Med Chem
; 56(8): 3367-78, 2013 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23540790
6.
α- and ß-hydrazino acid-based pseudopeptides inhibit the chymotrypsin-like activity of the eukaryotic 20S proteasome.
Eur J Med Chem
; 70: 505-24, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24185380
7.
Carbonylhydrazide-based molecular tongs inhibit wild-type and mutated HIV-1 protease dimerization.
J Med Chem
; 55(15): 6762-75, 2012 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22800535
8.
Toward the first nonpeptidic molecular tong inhibitor of wild-type and mutated HIV-1 protease dimerization.
ChemMedChem
; 5(11): 1899-906, 2010 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20936621